ENTRY       D02200                      Drug
NAME        Pilocarpine hydrochloride (JP18/USP);
            Isopto carpine (TN);
            Pilopine HS (TN);
            Salagen (TN);
            Sanpilo (TN)
PRODUCT     SALAGEN (Concordia Pharmaceuticals)
            VUITY (AbbVie)
  GENERIC   PILOCARPINE HYDRCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDRCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDRCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDRCHLORIDE (Padagis US LLC)
            PILOCARPINE HYDROCHLORIDE (AMICI PHARMACEUTICALS LLC)
            PILOCARPINE HYDROCHLORIDE (Actavis Pharma)
            PILOCARPINE HYDROCHLORIDE (Akorn)
            PILOCARPINE HYDROCHLORIDE (American Health Packaging)
            PILOCARPINE HYDROCHLORIDE (Amneal Pharmaceuticals NY LLC)
            PILOCARPINE HYDROCHLORIDE (Amneal Pharmaceuticals NY LLC)
            PILOCARPINE HYDROCHLORIDE (Aurobindo Pharma Limited)
            PILOCARPINE HYDROCHLORIDE (AvPAK)
            PILOCARPINE HYDROCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDROCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDROCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDROCHLORIDE (Bryant Ranch Prepack)
            PILOCARPINE HYDROCHLORIDE (Lannett Company)
            PILOCARPINE HYDROCHLORIDE (NorthStar Rx LLC)
            PILOCARPINE HYDROCHLORIDE (Sandoz)
            PILOCARPINE HYDROCHLORIDE (Somerset Therapeutics)
FORMULA     C11H16N2O2. HCl
EXACT_MASS  244.0979
MOL_WEIGHT  244.7179
CLASS       Neuropsychiatric agent
             DG01490  Muscarinic cholinergic receptor agonist
             DG01719  Parasympathomimetic agent
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
            Metabolizing enzyme substrate
             DG01638  CYP2A6 substrate
REMARK      Therapeutic category: 1312 2399
            ATC code: N07AX01 S01EB01
            Chemical structure group: DG00992
            Product (DG00992): D02200<JP/US>
EFFICACY    Antiglaucoma, Miotic, Salivation accelaletor, Muscarinic acetylcholine receptor agonist
  DISEASE   Open-angle glaucoma [DS:H00612]
            Sjogren's Syndrome [DS:H01502]
TARGET      CHRM3 [HSA:1131] [KO:K04131]
            CHRM2 [HSA:1129] [KO:K04130]
  PATHWAY   hsa04080(1129+1131)  Neuroactive ligand-receptor interaction
            hsa04725(1129+1131)  Cholinergic synapse
            hsa04970(1131)  Salivary secretion
METABOLISM  Enzyme: CYP2A6 [HSA:1548]
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
            map07220  Cholinergic and anticholinergic drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07A PARASYMPATHOMIMETICS
                N07AX Other parasympathomimetics
                 N07AX01 Pilocarpine
                  D02200  Pilocarpine hydrochloride (JP18/USP) &lt;JP/US&gt;
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01EB Parasympathomimetics
                 S01EB01 Pilocarpine
                  D02200  Pilocarpine hydrochloride (JP18/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Dental and Oral Agents
              Pilocarpine
               D02200  Pilocarpine hydrochloride (JP18/USP)
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Cholinergic Agonists, Ophthalmic
                Pilocarpine
                 D02200  Pilocarpine hydrochloride (JP18/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1312  Miotic agents
                 D02200  Pilocarpine hydrochloride (JP18/USP)
             2  Agents affecting individual organs
              23  Digestive organ agents
               239  Miscellaneous
                2399  Others
                 D02200  Pilocarpine hydrochloride (JP18/USP)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01490  Muscarinic cholinergic receptor agonist
               DG00992  Pilocarpine
                D02200  Pilocarpine hydrochloride
              DG01719  Parasympathomimetic agent
               DG00992  Pilocarpine
                D02200  Pilocarpine hydrochloride
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00992  Pilocarpine
                D02200  Pilocarpine hydrochloride
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00992  Pilocarpine
                D02200  Pilocarpine hydrochloride
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D02200  Pilocarpine hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM2
                 D02200  Pilocarpine hydrochloride (JP18/USP) &lt;JP/US&gt;
                CHRM3
                 D02200  Pilocarpine hydrochloride (JP18/USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D02200  Pilocarpine hydrochloride
              D02200  Pilocarpine hydrochloride tablets
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D02200
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01490  Muscarinic cholinergic receptor agonist
               DG00992  Pilocarpine
              DG01719  Parasympathomimetic agent
               DG00992  Pilocarpine
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG00992  Pilocarpine
             Metabolizing enzyme substrate
              DG01638  CYP2A6 substrate
               DG00992  Pilocarpine
DBLINKS     CAS: 54-71-7
            PubChem: 7849260
            LigandBox: D02200
            NIKKAJI: J231.249B
ATOM        16
            1   C1y C    22.9454  -19.7221
            2   C1y C    21.4986  -19.7221
            3   C1b C    24.1589  -20.3289
            4   C1x C    23.3654  -18.3687
            5   C7x C    21.0786  -18.3687
            6   C1b C    20.7052  -20.8422
            7   C8y C    25.2323  -19.7221
            8   O7x O    22.2454  -17.5286
            9   O6a O    19.7251  -17.9019
            10  C1a C    19.3051  -20.8422
            11  N4y N    26.6324  -19.7221
            12  C8x C    24.7656  -18.3687
            13  C8x C    27.0525  -18.3687
            14  C1a C    27.4725  -20.8422
            15  N5x N    25.9323  -17.5286
            16  X   Cl   29.8072  -18.8353
BOND        16
            1     1   2 1
            2     1   3 1 #Down
            3     1   4 1
            4     2   5 1
            5     2   6 1 #Down
            6     3   7 1
            7     4   8 1
            8     5   9 2
            9     6  10 1
            10    7  11 1
            11    7  12 2
            12   11  13 1
            13   11  14 1
            14   12  15 1
            15    5   8 1
            16   13  15 2
///
